← Eichor
Study identifier: NCT04399200 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Apnea, Stroke and Incident Cardiovascular Events

Condition: Stroke · Sleep-disordered Breathing · Sleep Apnea Syndromes  ·  Sponsor: University Hospital, Grenoble

PhaseN/A
Planned participants1620
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This prospective cohort study aims to compare the proportion of cardiac or cerebrovascular events after a first stroke, a first transient ischemic attack (TIA) or recurrent TIA, between sleep-disordered breathing (SDB) and non-SDB (control) patients, one year after SDB diagnosis, performed 3 months after stroke onset. The primary outcome is a composite endpoint composed of cardiac or cerebrovascular events regrouping: death from any cardiac or cerebrovascular cause, non-fatal stroke, and non-fatal acute coronary disease. 1620 patients, in the acute phase of a first stroke, TIA or recurrent TIA will be included in the cohort. Clinical, neuroimaging, sensorimotor, cognitive and biological parameters will be collected at inclusion. Three months after stroke or TIA onset, polysomnography will be performed for SDB diagnosis. Patients will be considered as having SDB for an Apnea-Hypopnea Index (AHI) \> 15 events/hour, or to the control group otherwise. The same clinical, imaging, cognitive and biological assessments than during the first visit will be performed; incident (new) cardiovascular events will be collected. Three months later, and at 1, 2, 3, 4 and 5 years after SDB diagnosis, the same clinical, cognitive, sensorimotor, and sleep-related evaluations will be performed. In addition to the aforementioned parameters, incident cardiovascular outcomes will be collected, at the same time points. The primary study outcome will be retrieved one year after stroke onset.

This description comes directly from the study's public registry record.

Talk to the study team

Sébastien Baillieul, MD, MSc  ·  +33 (0)4 76 76 75 40  ·  sbaillieul@chu-grenoble.fr

Sara Saadi, MSc  ·  +33 (0)4 76 76 86 90  ·  ssaadi1@chu-grenoble.fr

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital GrenobleGrenoble, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04399200